BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20947697)

  • 1. Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus.
    Lund SS; Petersen M; Frandsen M; Smidt UM; Parving HH; Vaag AA; Jensen T
    Clin Chem; 2011 Feb; 57(2):298-308. PubMed ID: 20947697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
    Fu ZF; Liu ML
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study.
    Alssema M; El-Harchaoui K; Schindhelm RK; Diamant M; Nijpels G; Kostense PJ; Teerlink T; Heine RJ; Dallinga-Thie GM; Kuivenhoven JA; Dekker JM; Scheffer PG
    Metabolism; 2010 Jun; 59(6):854-60. PubMed ID: 20005542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study.
    Trautwein EA; Koppenol WP; de Jong A; Hiemstra H; Vermeer MA; Noakes M; Luscombe-Marsh ND
    Nutr Diabetes; 2018 May; 8(1):30. PubMed ID: 29795368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State.
    Miida T; Nishimura K; Hirayama S; Miyamoto Y; Nakamura M; Masuda D; Yamashita S; Ushiyama M; Komori T; Fujita N; Yokoyama S; Teramoto T
    J Atheroscler Thromb; 2017 Jun; 24(6):583-599. PubMed ID: 28321014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of Calculated Low-Density Lipoprotein Cholesterol.
    Meeusen JW; Snozek CL; Baumann NA; Jaffe AS; Saenger AK
    Am J Cardiol; 2015 Aug; 116(4):538-40. PubMed ID: 26059865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia.
    Sheu WH; Jeng CY; Lee WJ; Lin SY; Pei D; Chen YT
    Metabolism; 2001 Mar; 50(3):355-9. PubMed ID: 11230791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
    al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes.
    Scheffer PG; Tushuizen ME; Vermue HP; Schindhelm RK; Rustemeijer C; Diamant M
    Eur J Clin Nutr; 2011 Nov; 65(11):1242-9. PubMed ID: 21712838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women.
    Mora S; Rifai N; Buring JE; Ridker PM
    Clin Chem; 2009 May; 55(5):888-94. PubMed ID: 19395440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.
    Evans M; Anderson RA; Graham J; Ellis GR; Morris K; Davies S; Jackson SK; Lewis MJ; Frenneaux MP; Rees A
    Circulation; 2000 Apr; 101(15):1773-9. PubMed ID: 10769276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.
    Bozzetto L; Annuzzi G; Corte GD; Patti L; Cipriano P; Mangione A; Riccardi G; Rivellese AA
    Atherosclerosis; 2011 Jul; 217(1):142-8. PubMed ID: 21481394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.
    Anderson RA; Evans LM; Ellis GR; Khan N; Morris K; Jackson SK; Rees A; Lewis MJ; Frenneaux MP
    Diabet Med; 2006 Mar; 23(3):258-64. PubMed ID: 16492208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of optimal cut-off points after a high-fat meal corresponding to fasting elevations of triglyceride and remnant cholesterol in Chinese subjects.
    Xu J; Chen YQ; Zhao SP; Liu L
    Lipids Health Dis; 2019 Nov; 18(1):206. PubMed ID: 31767005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
    Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH
    Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.